RAB5A and metastatic malignant neoplasm in the lymph nodes: Since Rab5A was also reported to be associated with lymph node metastasis in breast cancer patients [90], the reduction of this protein upon CB agonist exposure suggested the potential obstruction of breast cancer metastasis in the presence of CB agonists.